This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

NIH Consensus Development Panel on Impotence

JAMA. 1993;270(1):83-90.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE TERM impotence, as it has been applied to the title of this conference, has traditionally been used to signify the inability of the male to attain and maintain erection of the penis sufficient to permit satisfactory sexual intercourse. However, this use has often led to confusing and uninterpretable results in clinical and basic science investigations. This, together with its pejorative implications, suggests that the more precise term erectile dysfunction be used instead to signify an inability of the male to achieve an erect penis as part of the overall multifaceted process of male sexual function. This process comprises a variety of physical aspects with important psychological and behavioral overtones. In an effort to be precise in the analysis of the material discussed at this conference, this consensus report addresses issues of male erectile dysfunction as implied by use of the term impotence in the reports that have been presented. . . . [Full Text PDF of this Article]

Footnotes
NIH Consensus Development Conferences are convened to evaluate available scientific information and to resolve safety and efficacy issues related to a biomedical technology. The resultant NIH Consensus Statements are intended to advance understanding of the technology or issue in question and to be useful to health professionals and the public.

NIH Consensus Statements are prepared by a nonadvocacy, nonfederal panel of experts based on (1) presentations by investigators working in areas relevant to the consensus question during a 1 -day public session; (2) questions and statements from conference attendees during open discussion periods that are part of the public session; and (3) closed deliberations by the panel during the remainder of the second day and the morning of the third day. This statement is an independent report of the panel and is not a policy statement of the NIH or the federal government.

From the Office of Medical Applications of Research, National Institutes of Health, Bethesda, Md.

Reprint requests to Office of Medical Applications of Research, Federal Bldg, Room 618, National Institutes of Health, 7550 Wisconsin Ave, Bethesda, MD 20892 (William H. Hall). Bibliography, prepared by the National Library of Medicine, is available from the same address.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?